Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence) tackles lung and familial breast cancer

This article was originally published in Clinica

Executive Summary

The UK's National Institute for Clinical Excellence (NICE) is preparing to develop clinical guidelines for the diagnosis and treatment of lung cancer and for the identification and management of genetic risk of familial breast cancer. The work will add to the growing body of work that the institute is devoting to cancer-related topics. NICE was recently forced to defend its work in this area, after it was strongly criticised during a parliamentary inquiry on cancer research (see this page).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064332

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel